Oncotarget published "Epigenetic signatures differentiate uterine and soft tissue leiomyosarcoma" which reported that leiomyosarcomas are diverse, rare, and aggressive mesenchymal soft tissue sarcomas ...
Oncotarget recently published "A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo which reported that here, the authors describe ...
Volume 11, Issue 28 of Oncotarget features "Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry" by Schmidt et, al. which reported that ...
Dr. Mikhail V. Blagosklonny, M.D., Ph.D., Editor-in-Chief of Oncotarget, and Professor, at Roswell Park Cancer Institute, published "The goal of geroscience is life extension" which was selected as ...
Non-Hodgkin’s lymphoma (NHL) is the seventh leading cause of cancer in the US, with 20-40% of patients experiencing relapsed or refractory disease with limited or no therapeutic options. Publication ...
A new research paper titled "Initiation of tumor dormancy by the lymphovascular embolus" has been published in Oncotarget Researchers Yin Ye, Justin Wang, Michael G. Izban, Billy R. Ballard, and ...
The landscape of treatment and overall survival analysis of elderly patients with advanced breast cancer in China National Cancer Center. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results